These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 26827662)
1. Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model. Al Faraj A; Shaik AS; Ratemi E; Halwani R J Control Release; 2016 Mar; 225():240-51. PubMed ID: 26827662 [TBL] [Abstract][Full Text] [Related]
2. Preferential magnetic targeting of carbon nanotubes to cancer sites: noninvasive tracking using MRI in a murine breast cancer model. Al Faraj A; Shaik AS; Al Sayed B Nanomedicine (Lond); 2015; 10(6):931-48. PubMed ID: 25867858 [TBL] [Abstract][Full Text] [Related]
3. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981 [TBL] [Abstract][Full Text] [Related]
4. Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker. Al Faraj A; Shaik AP; Shaik AS Int J Nanomedicine; 2015; 10():157-68. PubMed ID: 25565811 [TBL] [Abstract][Full Text] [Related]
5. Specific targeting and noninvasive imaging of breast cancer stem cells using single-walled carbon nanotubes as novel multimodality nanoprobes. Al Faraj A; Shaik AS; Al Sayed B; Halwani R; Al Jammaz I Nanomedicine (Lond); 2016 Jan; 11(1):31-46. PubMed ID: 26673059 [TBL] [Abstract][Full Text] [Related]
6. Effective deactivation of A549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel. Li B; Zhang XX; Huang HY; Chen LQ; Cui JH; Liu Y; Jin H; Lee BJ; Cao QR Int J Pharm; 2018 May; 543(1-2):8-20. PubMed ID: 29535039 [TBL] [Abstract][Full Text] [Related]
7. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells. Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852 [TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy. Narayanaswamy R; Torchilin VP Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395 [TBL] [Abstract][Full Text] [Related]
10. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491 [TBL] [Abstract][Full Text] [Related]
11. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients. He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092 [TBL] [Abstract][Full Text] [Related]
12. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment. Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197 [TBL] [Abstract][Full Text] [Related]
13. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123 [TBL] [Abstract][Full Text] [Related]
14. Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells. Zeng YB; Yu ZC; He YN; Zhang T; Du LB; Dong YM; Chen HW; Zhang YY; Wang WQ Acta Pharmacol Sin; 2018 Feb; 39(2):261-274. PubMed ID: 29388568 [TBL] [Abstract][Full Text] [Related]
15. Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells. Li L; Cui D; Ye L; Li Y; Zhu L; Yang L; Bai B; Nie Z; Gao J; Cao Y Anticancer Drugs; 2017 Oct; 28(9):989-1001. PubMed ID: 28692437 [TBL] [Abstract][Full Text] [Related]
16. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer. Swaminathan SK; Roger E; Toti U; Niu L; Ohlfest JR; Panyam J J Control Release; 2013 Nov; 171(3):280-7. PubMed ID: 23871962 [TBL] [Abstract][Full Text] [Related]
17. Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model. Shao W; Paul A; Zhao B; Lee C; Rodes L; Prakash S Biomaterials; 2013 Dec; 34(38):10109-19. PubMed ID: 24060420 [TBL] [Abstract][Full Text] [Related]
18. iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells. Mao X; Liu J; Gong Z; Zhang H; Lu Y; Zou H; Yu Y; Chen Y; Sun Z; Li W; Li B; Gao J; Zhong Y Nanomedicine (Lond); 2015; 10(17):2677-95. PubMed ID: 26355733 [TBL] [Abstract][Full Text] [Related]
19. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells. Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs. Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]